Docusign (NASDAQ:DOCU) Director Anna Marrs Sells 365 Shares of Stock

Docusign Inc. (NASDAQ:DOCU) Director Anna Marrs sold 365 shares of Docusign stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $55.04, for a total transaction of $20,089.60. Following the transaction, the director directly owned 12,615 shares of the company’s stock, valued at $694,329.60. This represents a 2.81% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Anna Marrs also recently made the following trade(s):

• On Thursday, March 5th, Anna Marrs sold 363 shares of Docusign stock. The stock was sold at an average price of $46.33, for a total transaction of $16,817.79.

Docusign Stock Down 3.4%

Shares of NASDAQ DOCU opened at $55.10 on Wednesday. Docusign Inc. has a twelve month low of $40.16 and a twelve month high of $94.67. The firm has a fifty day simple moving average of $47.41 and a 200 day simple moving average of $54.53. The company has a market capitalization of $10.71 billion, a PE ratio of 37.23, a P/E/G ratio of 2.17 and a beta of 0.92.

Docusign (NASDAQ:DOCU) last announced its earnings results on Tuesday, March 17th. The company reported $1.01 earnings per share for the quarter, topping analysts’ consensus estimates of $0.95 by $0.06. Docusign had a net margin of 9.60% and a return on equity of 16.86%. The business had revenue of $836.86 million during the quarter, compared to the consensus estimate of $828.23 million. During the same quarter last year, the firm earned $0.86 earnings per share. Docusign’s quarterly revenue was up 7.8% on a year-over-year basis. As a group, equities analysts expect that Docusign Inc. will post 1.76 earnings per share for the current fiscal year.

Docusign declared that its Board of Directors has authorized a share repurchase program on Tuesday, March 17th that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the company to buy up to 21% of its shares through open market purchases. Shares buyback programs are typically a sign that the company’s leadership believes its shares are undervalued.

Docusign News Roundup

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Docusign announced its app is now available in ChatGPT and Codex, extending its Intelligent Agreement Management platform into OpenAI products and potentially boosting adoption by making it easier for customers to create, analyze, and manage agreements with natural-language prompts. Docusign Brings Trusted Agreement Intelligence and Workflows into ChatGPT and Codex
• Positive Sentiment: The company also named Graham Sheldon as Chief Product Officer, a move aimed at accelerating its AI-focused product strategy and strengthening execution around its Intelligent Agreement Management vision. Docusign Appoints Graham Sheldon as Chief Product Officer to Accelerate Intelligent Agreement Management Vision
• Neutral Sentiment: Several directors disclosed stock sales, including Anna Marrs, James A. Beer, and Teresa Briggs. The transactions were relatively small and were executed under pre-arranged Rule 10b5-1 plans, which usually makes them less concerning for investors. SEC filing: Anna Marrs Form 4
• Neutral Sentiment: Investor attention is also focused on Docusign’s June 4 earnings report, with recent commentary suggesting the market wants proof that its AI-driven product strategy is translating into stronger execution. Dear Docusign Stock Fans, Mark Your Calendars for June 4

Wall Street Analyst Weigh In

DOCU has been the subject of a number of analyst reports. JPMorgan Chase & Co. lowered their target price on shares of Docusign from $78.00 to $65.00 and set a “neutral” rating for the company in a research note on Wednesday, March 18th. Citigroup downgraded shares of Docusign from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $99.00 to $50.00 in a research note on Friday, April 10th. UBS Group lowered their target price on shares of Docusign from $75.00 to $54.00 and set a “neutral” rating for the company in a research note on Wednesday, March 18th. Needham & Company LLC reissued a “hold” rating on shares of Docusign in a research note on Tuesday, March 10th. Finally, Royal Bank Of Canada reduced their price target on shares of Docusign from $70.00 to $55.00 and set a “sector perform” rating for the company in a report on Wednesday, March 18th. Three investment analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, Docusign has a consensus rating of “Hold” and an average target price of $61.40.

Institutional Investors Weigh In On Docusign

A number of large investors have recently bought and sold shares of the stock. EverSource Wealth Advisors LLC grew its holdings in Docusign by 15.1% in the third quarter. EverSource Wealth Advisors LLC now owns 1,229 shares of the company’s stock worth $89,000 after purchasing an additional 161 shares during the period. Smartleaf Asset Management LLC grew its holdings in Docusign by 8.2% in the second quarter. Smartleaf Asset Management LLC now owns 2,169 shares of the company’s stock worth $166,000 after purchasing an additional 165 shares during the period. Centaurus Financial Inc. grew its holdings in Docusign by 3.4% in the third quarter. Centaurus Financial Inc. now owns 5,582 shares of the company’s stock worth $402,000 after purchasing an additional 184 shares during the period. Clearstead Advisors LLC grew its holdings in Docusign by 12.1% in the third quarter. Clearstead Advisors LLC now owns 1,872 shares of the company’s stock worth $135,000 after purchasing an additional 202 shares during the period. Finally, Tred Avon Family Wealth LLC grew its holdings in Docusign by 3.6% in the first quarter. Tred Avon Family Wealth LLC now owns 6,176 shares of the company’s stock worth $293,000 after purchasing an additional 215 shares during the period. 77.64% of the stock is currently owned by institutional investors and hedge funds.

About Docusign

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.